Did Novo Nordisk executive faint in Oval Office? Company clarifies amid buzz about Gordon Findlay

Man Faints During Oval Office Press Conference

During a White House press conference on Thursday, a man fainted in the Oval Office. At the time, President Donald Trump was announcing a deal with drugmakers aimed at lowering the cost of obesity medications.

Incident Details and Reactions

The video showing the man collapsing was widely shared online. Independent journalist Eric Daugherty posted the footage, stating:

“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him.”

He also urged viewers to “Pray for him.” Many viewers sent well-wishes for the man's recovery, although the live feed was cut short.

Confusion Over Identity

The man was initially identified as Gordon Findlay, with some claiming he was a Novo Nordisk executive. One social media post read:

“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”

Company Clarification

However, Novo Nordisk clarified that the man was not their employee. The company stated:

“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”

White House Statement

White House Press Secretary Karoline Leavitt confirmed the incident, commenting:

“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”

Summary: A man fainted during President Trump's Oval Office announcement on obesity drug pricing, initially misidentified as a Novo Nordisk executive, but the company denied this and confirmed only two representatives were present.

Would you like the summary to be more formal or conversational?

more

Hindustan Times Hindustan Times — 2025-11-06